Prostate Cancer: an Overview

Is Sentinel Node Detection Helpful in the Curative Treatment of Prostate Cancer?


Prostate Cancer Sentinel Lymph Node Radical Prostatectomy Gleason Score Prostate Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbas F, Scardino T (1993) Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol Clin North Am 23:587–604CrossRefGoogle Scholar
  2. Allsbrook WC Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologists. Hum Pathol 32(1):81–88CrossRefPubMedGoogle Scholar
  3. Altay B, Kefi A, Nazli O, Killi R, Semerci B, Akar I (2001) Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens. Urol Int 67(1):14–18CrossRefPubMedGoogle Scholar
  4. Arduino LJ, Glucksman MA (1962) Lymph node metastases in early carcinoma of the prostate. J Urol 88:91PubMedGoogle Scholar
  5. Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr (1977) Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol Vol 118:278–282Google Scholar
  6. Batson OV (1940) Function of vertebral veins and their role in spread of metastases. Ann Surg 112:138Google Scholar
  7. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fossa SD (1995) DNA “ploidy” serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3 M0 prostatic adenocarcinoma. Br J Urol 75:26–32PubMedGoogle Scholar
  8. Beurton D, Barthélémy Y, Fontaine E (1997) Twelve systematic prostate biopsies are superior to sectant biopsies for diagnosing carcinoma: a prospective randomized study. Br J Urol 80:239Google Scholar
  9. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151:1315–1320PubMedGoogle Scholar
  10. Bostwick DG, Eble JN (1993) Prostatic adenocarcinoma metastatic to inguinal hernia sac. J Urol Pathol 1:193Google Scholar
  11. Brendler CB, Cleeve LK, Anderson EE, Paulson DF (1980) Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J Urol 124:849PubMedGoogle Scholar
  12. Bruce AW, O'Cleireachain F, Morales A, Awas SA (1977) Carcinoma of the prostate: a critical look at staging. J Urol 117:319PubMedGoogle Scholar
  13. Carlson GD, Calvanese CB, Kahane H, Epstein JI (1998) Accuracy of biopsy Gleason score from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. Urology 51(4):525–529CrossRefPubMedGoogle Scholar
  14. Catalona WJ, Stein AJ (1982) Staging errors in clinically localized prostatic cancer. J Urol 127:452PubMedGoogle Scholar
  15. Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152:1837–1842PubMedGoogle Scholar
  16. Cheng CWS, Bergstralh EJ, Zincke H (1993) Stage D1 prostate cancer: a non randomized comparison of conservative treatment options versus radical prostatectomy. Cancer Suppl 71(3):996–1004Google Scholar
  17. Conrad St, Graefen M, Pichlmeier U, Henke RP, Hammerer PG, Huland H (1998) Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 159:2023–2029CrossRefPubMedGoogle Scholar
  18. Danella JF, Kernion JB de, Smith RB, Steckel J (1993) The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149:1488–1491PubMedGoogle Scholar
  19. Davies GL (1995) Sensitivity of frozen section examination of pelvic lymph-nodes for metastatic prostate cancer. Cancer 75:662–668Google Scholar
  20. Dillioglugil O, Leibman BD, Leibman NS, Kattan MW, Rosas AL, Scardino PT (1997) Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157:1760–1767CrossRefPubMedGoogle Scholar
  21. Donohue RE, Mani JH, Whitesel JA, Mohr S, Scanavino D, Augspurger RR, Biber RJ, Fauver HE, Wettlaufer JN, Pfister RR (1982) Pelvic lymph node dissection. Guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20:559CrossRefPubMedGoogle Scholar
  22. Effert PJ, Bares R, Handt S, Wolf JM, Bull U, Jakse G (1996) Metabolic imaging of untreated prostate cancer by positron emission tomography with 18-fluorine-labeled deoxyglucose. J Urol 155:994–998CrossRefPubMedGoogle Scholar
  23. Epstein JI, Oesterling JE, Eggleston JC, Walsh PC (1986) Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol 136:1234–1237PubMedGoogle Scholar
  24. Eskew LA, Bare RL, McCullough DL (1996) Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157:199Google Scholar
  25. Flocks RH, Culp D, Porto R (1959) Lymphatic spread from prostatic cancer. J Urol 81:194PubMedGoogle Scholar
  26. Földi M, Kubik S (2002) Lehrbuch der Lymphologie, 5th edn, p 150. Urban and Fischer, MunichGoogle Scholar
  27. Fowler JE Jr, Whitmore WF Jr (1981) The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 57:2941Google Scholar
  28. Frazier HA II, Robertson JE, Paulson DF (1994) Does radical prostatectomy in the presence of positive pelvic lymph-nodes enhance survival. World J Urol 12:308–312CrossRefPubMedGoogle Scholar
  29. Freiha FS, Salzman J (1977) Surgical staging of prostatic cancer: transperitoneal versus extraperitoneal lymphadenectomy. J Urol 118:616PubMedGoogle Scholar
  30. Freiha FS, Pistenma DA, Bagshaw MA (1979) Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary? J Urol 122:176PubMedGoogle Scholar
  31. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE Jr, Scardino PT (1989) Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142:332PubMedGoogle Scholar
  32. Gomella LG, White JL, McCue PA, Byrne DS, Mulholland SG (1993) Screening for occult nodal metastasis in localized carcinoma of the prostate. J Urol 149:776–778PubMedGoogle Scholar
  33. Gregori A, Vieweg J, Dahm P, Paulson DF (2001) Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int 66(2):66–71CrossRefPubMedGoogle Scholar
  34. Grossman IC, Carpinielle V, Greenberg SH, Malloy TR, Wein AJ (1980) Staging pelvic lymphadenectomy for carcinoma of the prostate: review of 91 cases. J Urol 124:632PubMedGoogle Scholar
  35. Hanks GE (1993) The challenge of treating node positive prostate cancer. An approach to resolving the questions. Cancer 71[3 Suppl]:1014–1018PubMedGoogle Scholar
  36. Haseman MK, Reed NL, Rosenthal SA (1996) Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation. Clin Nucl Med 21:704–713CrossRefPubMedGoogle Scholar
  37. Hofer C, Laubenbacher C, Block T et al (1999) Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 36:31–35CrossRefGoogle Scholar
  38. Huland H (1998) Welchen Stellenwert hat die radikale Prostatektomie beim Lymphknoten positiven Prostatacarcinom? Urologe 37:138–140CrossRefPubMedGoogle Scholar
  39. King CR, Long JP (2000) Prostate biopsy grading errors: a sampling problem? Int J Cancer 90(6):326–330CrossRefPubMedGoogle Scholar
  40. Koksal IT, Ozcan F, Kadioglu TC, Esen T, Kilicaslan I, Tune M (2000) Discrepancy between Gleason score of biopsy and radical prostatectomy specimens. Eur Urol 37(6): 670–674CrossRefPubMedGoogle Scholar
  41. Kozlowski JM, Grayhack JT (1987) Carcinoma of the prostate. In: Gillenwater JY, Grayhack JT, Howard SS, Duckett JW (eds) Adult and pediatric urology, vol 2, chap 34. Year Book Medical Publishers, Chicago, pp 1126–1130Google Scholar
  42. Kramer STA, Cline WA Jr, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DF (1981) Prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol 125:817–819PubMedGoogle Scholar
  43. Leibovitch I, Westenfelder K, Vaught J, Rowland RG (1995) Orthostatic abnormal penile erections: a consequence of retroperitoneal lymphadenectomy with vena caval resection. J Urol 154:533–534CrossRefPubMedGoogle Scholar
  44. Lieskovsky G, Skinner DG (1983) Technique of radical retropubic prostatectomy with limited pelvic node dissection. Urol Clin N Am 10:187Google Scholar
  45. Lilleby W, Torlakovic G, Torlakovic E, Skovlund E, Fossa SD (2001) Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy. Cancer 92:311–319CrossRefPubMedGoogle Scholar
  46. Loening SA, Schmidt JD, Brown RC, Hawtrey CE, Fallon B, Culp DA (1977) A comparison between lymphangiography and pelvic node dissection in the staging of prostatic cancer. J Urol 117:752PubMedGoogle Scholar
  47. McCarthy P, Pollak HM (1991) Imaging of patients with stage D prostatic carcinoma. Urol Clin N Am 18:35Google Scholar
  48. McCullough DL, McLaughlin AR Gittes RF (1977) Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostatic cancer. J Urol 117:206PubMedGoogle Scholar
  49. McCullough DL, Prout GR Jr, Daly JJ (1974) Carcinoma of the prostate and lymphatic metastases. J Urol 111:65PubMedGoogle Scholar
  50. McDowell GC II, Johnson JW, Tenney DM, Johnson DE (1990) Pelvic lymphadenectomy for staging clinically localized prostatic cancer. Indications, complications, and results in 217 cases. Urology 35:476CrossRefPubMedGoogle Scholar
  51. McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF (1976) Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115:89PubMedGoogle Scholar
  52. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA (1990) Histologic differentiation, cancer volume and pelvic lymph node metastases in adenocarcinoma of the prostate. Cancer 66:1225–1233PubMedGoogle Scholar
  53. McNeal JE (1993) Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer. Cancer (Suppl 3) 71:984–991PubMedGoogle Scholar
  54. Moul JW, Lewis DJ, Ross AA, Kahn DG, Ho CH, McLeod DG (1994) Immunohistologic detection of prostate cancer pelvic lymph node micrometastases correlation to preoperative serum prostate specific antigen. Urology 43:68CrossRefPubMedGoogle Scholar
  55. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection. J Urol 164:388–392CrossRefPubMedGoogle Scholar
  56. Nicholson TC, Richie JP (1977) Pelvic lymphadenectomy for stage Bl adenocarcinoma of the prostate: justified or not? J Urol 117(2):199–201PubMedGoogle Scholar
  57. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Brucek DJ, Rock RC, Brendler CB, Walsh PC (1988) Prostate-specific antigen in the preoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766–772PubMedGoogle Scholar
  58. Okegawa T, Nutahara K, Higashihara E (2000) Detection of micrometastatic prostate cancer cells in the lymph-nodes by reverse transcriptase polymerize chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer. J Urol 163:1183–1188CrossRefPubMedGoogle Scholar
  59. Parra RO, Andrus C, Boullier J (1992) Staging laparoscopic pelvic lymph node dissection comparison of results with open pelvic lymphadenectomy. J Urol 157:875–878Google Scholar
  60. Parra RO, Isorna S, Perez MG, Cummings JM, Boullier JA (1996) Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results. J Urol 155:612–615CrossRefPubMedGoogle Scholar
  61. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC (1990) Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747–752PubMedGoogle Scholar
  62. Paulson DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin N Am 7:615Google Scholar
  63. Paulson DF (1989) Remark to the publication of Gervasi et al. J Urol 142:336Google Scholar
  64. Petros JA, Catalona WJ (1992) Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147:1574–1575PubMedGoogle Scholar
  65. Ravery V, Billeboud T, Toublanc M, Boccon-Gibod L, Hermieu JF, Moulinier F, Blank E, Delmas V, Boccon-Gibod L (1999) Diagnostic value of ten systematic TRUS-guided prostate biopsies. Eur Urol 35:298CrossRefPubMedGoogle Scholar
  66. Schüssler WW, Pharaud D, Caillie TG van (1993) Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate. J Urol 150:898–901PubMedGoogle Scholar
  67. See WA, Cohen MB, Winfield HN (1993) Inverted V-peritoneotomy significantly improves nodal yield in laparoscopic pelvic lymphadenectomy. J Urol 149:772–775PubMedGoogle Scholar
  68. Shreve PD, Grossman HB, Gross MD, Wahl RL (1996) Meta-static prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 199:751–756PubMedGoogle Scholar
  69. Smith JA Jr, Seaman JP, Gleidman JB, Middleton RG (1983) Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients. J Urol 130:290–292PubMedGoogle Scholar
  70. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whitmore AS, Schmid HP (1993) Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(Suppl 3):933–938PubMedGoogle Scholar
  71. Vogt H, Wawroschek F, Wengenmair H, Wagner T, Kopp J, Dorn R, Gröber S, Heidenreich P (2002) Sentinel lymph node diagnostic in prostate carcinoma. Technique and clinical evaluation. Nuklearmedizin 41:95–101PubMedGoogle Scholar
  72. Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152:1831–1836PubMedGoogle Scholar
  73. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R (1999) The sentinel lymph node concept in prostate cancer — first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36:595–600CrossRefPubMedGoogle Scholar
  74. Wawroschek F, Vogt H, Bachter D, Weckermann D, Hamm M, Harzmann R (2000) First experience with gamma probe guided sentinel lymph node surgery in penile cancer. Urol Res 28:246–249CrossRefPubMedGoogle Scholar
  75. Weingärtner K, Ramaswamy A, Bittinger A, Gerharz EW, Döge D, Riedmiller H (1996) Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156: 1969–1971CrossRefPubMedGoogle Scholar
  76. Whitmore WF Jr (1984) Natural history and staging of prostate cancer. Urol Clin N Am 11:205Google Scholar
  77. Wilson CS, Dahl DS, Middleton RG (1977) Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 117:197PubMedGoogle Scholar
  78. Winfield HN, Kavoussi LR (1991) Laparoscopic pelvic node dissection. Surg Tech Urol 4:1Google Scholar
  79. Winfield HN, Donovan JF, See WA, Loening SA, Williams RD (1991) Urological laparoscopic surgery. J Urol 146: 941PubMedGoogle Scholar
  80. Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI (1996) Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol 23:693–697CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations